Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP499457.RAq9_Px7jbHrOeUdlGXw1A6r2-Agc1QsMrDjHe4pBURc4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP499457.RAq9_Px7jbHrOeUdlGXw1A6r2-Agc1QsMrDjHe4pBURc4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP499457.RAq9_Px7jbHrOeUdlGXw1A6r2-Agc1QsMrDjHe4pBURc4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP499457.RAq9_Px7jbHrOeUdlGXw1A6r2-Agc1QsMrDjHe4pBURc4130_provenance.
- NP499457.RAq9_Px7jbHrOeUdlGXw1A6r2-Agc1QsMrDjHe4pBURc4130_assertion description "[These results suggest that inhibition of ROCK I may be a novel therapeutic target for preventing thromboembolic complications of diabetes and cardiovascular disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499457.RAq9_Px7jbHrOeUdlGXw1A6r2-Agc1QsMrDjHe4pBURc4130_provenance.
- NP499457.RAq9_Px7jbHrOeUdlGXw1A6r2-Agc1QsMrDjHe4pBURc4130_assertion evidence source_evidence_literature NP499457.RAq9_Px7jbHrOeUdlGXw1A6r2-Agc1QsMrDjHe4pBURc4130_provenance.
- NP499457.RAq9_Px7jbHrOeUdlGXw1A6r2-Agc1QsMrDjHe4pBURc4130_assertion SIO_000772 15956119 NP499457.RAq9_Px7jbHrOeUdlGXw1A6r2-Agc1QsMrDjHe4pBURc4130_provenance.
- NP499457.RAq9_Px7jbHrOeUdlGXw1A6r2-Agc1QsMrDjHe4pBURc4130_assertion wasDerivedFrom befree-2016 NP499457.RAq9_Px7jbHrOeUdlGXw1A6r2-Agc1QsMrDjHe4pBURc4130_provenance.
- NP499457.RAq9_Px7jbHrOeUdlGXw1A6r2-Agc1QsMrDjHe4pBURc4130_assertion wasGeneratedBy ECO_0000203 NP499457.RAq9_Px7jbHrOeUdlGXw1A6r2-Agc1QsMrDjHe4pBURc4130_provenance.
- befree-2016 importedOn "2016-02-19" NP499457.RAq9_Px7jbHrOeUdlGXw1A6r2-Agc1QsMrDjHe4pBURc4130_provenance.